Beta-lactam and Beta-lactamase Inhibitors Market Report

Global and Region Beta-lactam and Beta-lactamase Inhibitors Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：227
  • REPORT CODE：GMM922056
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Beta-lactam and Beta-lactamase Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Beta-lactam and Beta-lactamase Inhibitorsmarket, defines the market attractiveness level of Beta-lactam and Beta-lactamase Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Beta-lactam and Beta-lactamase Inhibitors industry, describes the types of Beta-lactam and Beta-lactamase Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Beta-lactam and Beta-lactamase Inhibitors market and the development prospects and opportunities of Beta-lactam and Beta-lactamase Inhibitors industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Beta-lactam and Beta-lactamase Inhibitors market in Chapter 13.

    By Player:

    • GlaxoSmithKline plc

    • Abbott Laboratories

    • Sanofi

    • Merck & Co Inc

    • Mylan NV

    • Pfizer Inc

    • Novartis International AG (Sandoz)

    • Allergan Plc

    • F Hoffmann-La Roche Ltd

    • Teva Pharmaceutical Industries Ltd

    By Type:

    • Penicillin

    • Cephalosporin

    • Carbapenem

    • Monobactam

    • Combination

    By End-User:

    • Oral

    • Intravenous

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Beta-lactam and Beta-lactamase Inhibitors Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Beta-lactam and Beta-lactamase Inhibitors Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Beta-lactam and Beta-lactamase Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Beta-lactam and Beta-lactamase Inhibitors Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Outlook to 2022

    • 7.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.2 United States Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.3 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.4 China Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.5 Japan Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.6 India Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    • 7.7 South Korea Beta-lactam and Beta-lactamase Inhibitors Consumption (2017-2022)

    8 Region and Country-wise Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Outlook to 2028

    • 8.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.2 United States Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.3 Europe Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.4 China Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.5 Japan Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.6 India Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    • 8.7 South Korea Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast (2022-2028)

    9 Global Beta-lactam and Beta-lactamase Inhibitors Market Outlook by Types and Applications to 2022

    • 9.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Penicillin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cephalosporin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Carbapenem Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Monobactam Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Combination Consumption and Growth Rate (2017-2022)

    • 9.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Intravenous Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Beta-lactam and Beta-lactamase Inhibitors Market Outlook by Types and Applications to 2028

    • 10.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Penicillin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Carbapenem Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Monobactam Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Combination Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Beta-lactam and Beta-lactamase Inhibitors Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Beta-lactam and Beta-lactamase Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Beta-lactam and Beta-lactamase Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Beta-lactam and Beta-lactamase Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Beta-lactam and Beta-lactamase Inhibitors Market Competitive Analysis

    • 14.1 GlaxoSmithKline plc

      • 14.1.1 GlaxoSmithKline plc Company Details

      • 14.1.2 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.2 Abbott Laboratories

      • 14.2.1 Abbott Laboratories Company Details

      • 14.2.2 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.4 Merck & Co Inc

      • 14.4.1 Merck & Co Inc Company Details

      • 14.4.2 Merck & Co Inc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck & Co Inc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.5 Mylan NV

      • 14.5.1 Mylan NV Company Details

      • 14.5.2 Mylan NV Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Mylan NV Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.6 Pfizer Inc

      • 14.6.1 Pfizer Inc Company Details

      • 14.6.2 Pfizer Inc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Inc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.7 Novartis International AG (Sandoz)

      • 14.7.1 Novartis International AG (Sandoz) Company Details

      • 14.7.2 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.8 Allergan Plc

      • 14.8.1 Allergan Plc Company Details

      • 14.8.2 Allergan Plc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Allergan Plc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.9 F Hoffmann-La Roche Ltd

      • 14.9.1 F Hoffmann-La Roche Ltd Company Details

      • 14.9.2 F Hoffmann-La Roche Ltd Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 F Hoffmann-La Roche Ltd Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • 14.10 Teva Pharmaceutical Industries Ltd

      • 14.10.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.10.2 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Beta-lactam and Beta-lactamase Inhibitors

    • Figure Beta-lactam and Beta-lactamase Inhibitors Picture

    • Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Beta-lactam and Beta-lactamase Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Beta-lactam and Beta-lactamase Inhibitors Consumption by Country (2017-2022)

    • Figure United States Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Table Europe Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure China Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Japan Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure India Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure South Korea Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast by Country (2022-2028)

    • Figure United States Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Penicillin Consumption and Growth Rate (2017-2022)

    • Figure Global Cephalosporin Consumption and Growth Rate (2017-2022)

    • Figure Global Carbapenem Consumption and Growth Rate (2017-2022)

    • Figure Global Monobactam Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Penicillin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carbapenem Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monobactam Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Beta-lactam and Beta-lactamase Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Beta-lactam and Beta-lactamase Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Mylan NV (Foundation Year, Company Profile and etc.)

    • Table Mylan NV Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NV Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Novartis International AG (Sandoz) (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Allergan Plc (Foundation Year, Company Profile and etc.)

    • Table Allergan Plc Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Beta-lactam and Beta-lactamase Inhibitors Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US